ARTICLE | Clinical News
Begedina regulatory update
October 4, 2010 7:00 AM UTC
The COMP issued a positive opinion to grant Orphan Drug designation for Adienne's Begedina to treat graft-versus-host disease (GvHD). Begedina is a murine antibody against the CD26 antigen of hematopo...